World Am Inc. reported that Senz-It Inc. has been awarded a United States Air Force biological development contract, worth up to $417,000. Under terms of the agreement, Senz-It will have the opportunity to prove the feasibility of its detection technology by providing test stations to detect and measure biological substances that are potential threats to the U.S. military. Under the terms of the agreement, the company will be reimbursed for expenses, up to $417,000, spent to set up and test its detection technology for the United States Air Force. The company also announced that it has already submitted a proposal for a follow-on second phase of this detection effort that, if granted, could lead to additional fees of $1,400,000 in 2008. Senz-It´s core detection technology, developed to detect and measure biological substances, is based on molecular imprinted xerogels with a fluorescent report molecule, affixed to the immediate proximity of the target´s binding site within the xerogel. Senz-It technology´s unique advantages include: Specificity comparable to monoclonal antibodies, but processed and detected in seconds, not hours; Robustness and stability under extreme chemical and physical environmental conditions; Detection capabilities with minimal cross-reaction among neighboring analytes, and An extremely low false-positive detection rate.

World Am Inc. announced that it has moved its corporate headquarters to a 20,000 square foot facility, leaving the 3,500 square foot office it formerly occupied. The new headquarters location is 4340 Von Karman, Newport Beach, Calif. 92660. The main phone number of 949-955-5355 and fax number of 949-955-2739 remain the same.

World Am Inc. reported revenue results for the year ended December 31, 2006. The company reported revenues of $245, 476 for the year ended December 31, 2006.